AJJ Medtech Holdings Limited (SGX:584)
Singapore
· Delayed Price · Currency is SGD 0.0020
0.00 (0.00%)
At close: Jun 16, 2025
AJJ Medtech Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2.56 | 2.32 | 1.62 | 0.6 | 0.32 | 0.68 | Upgrade
|
| Revenue | 2.56 | 2.32 | 1.62 | 0.6 | 0.32 | 0.68 | Upgrade
|
| Revenue Growth (YoY) | 24.58% | 43.84% | 170.97% | 86.83% | -53.29% | 229.95% | Upgrade
|
| Cost of Revenue | 1.73 | 1.74 | 0.92 | 0.28 | 0.05 | - | Upgrade
|
| Gross Profit | 0.82 | 0.59 | 0.7 | 0.31 | 0.27 | 0.68 | Upgrade
|
| Selling, General & Admin | 4.25 | 4.55 | 3.27 | 4.28 | 4.37 | 2.54 | Upgrade
|
| Other Operating Expenses | -0.06 | -0.07 | -0.06 | -0.08 | -0.18 | 0.92 | Upgrade
|
| Operating Expenses | 4.18 | 4.48 | 3.21 | 4.19 | 4.19 | 3.46 | Upgrade
|
| Operating Income | -3.36 | -3.89 | -2.51 | -3.88 | -3.92 | -2.78 | Upgrade
|
| Interest Expense | -0.06 | -0.05 | -0.06 | -0.06 | -0.08 | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -3.42 | -3.95 | -2.57 | -3.94 | -3.99 | -2.88 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 1.88 | - | Upgrade
|
| Asset Writedown | - | - | - | -0.05 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | 0.37 | - | Upgrade
|
| Other Unusual Items | 0.08 | 0.08 | 0 | 0.01 | - | 0.07 | Upgrade
|
| Pretax Income | -3.34 | -3.87 | -2.56 | -3.98 | -1.74 | -2.81 | Upgrade
|
| Income Tax Expense | -0.02 | -0 | -0.01 | -0.28 | -0 | -0 | Upgrade
|
| Earnings From Continuing Operations | -3.33 | -3.87 | -2.56 | -3.7 | -1.73 | -2.8 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 0.03 | -0.54 | - | - | Upgrade
|
| Net Income to Company | -3.33 | -3.87 | -2.53 | -4.24 | -1.73 | -2.8 | Upgrade
|
| Minority Interest in Earnings | -0.07 | - | - | - | 0.04 | 0.03 | Upgrade
|
| Net Income | -3.4 | -3.87 | -2.53 | -4.24 | -1.7 | -2.77 | Upgrade
|
| Net Income to Common | -3.4 | -3.87 | -2.53 | -4.24 | -1.7 | -2.77 | Upgrade
|
| Shares Outstanding (Basic) | 1,414 | 1,367 | 934 | 934 | 934 | 770 | Upgrade
|
| Shares Outstanding (Diluted) | 1,414 | 1,367 | 934 | 934 | 934 | 770 | Upgrade
|
| Shares Change (YoY) | 37.41% | 46.39% | - | - | 21.32% | 15.18% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -0.99 | -1.62 | -1.74 | -3.24 | -6.04 | -1.17 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | Upgrade
|
| Gross Margin | 32.23% | 25.27% | 43.28% | 52.35% | 84.95% | 100.00% | Upgrade
|
| Operating Margin | -131.40% | -167.63% | -155.29% | -651.17% | -1228.53% | -406.59% | Upgrade
|
| Profit Margin | -132.77% | -166.38% | -156.47% | -711.58% | -531.66% | -405.71% | Upgrade
|
| Free Cash Flow Margin | -38.60% | -69.91% | -107.93% | -543.29% | -1894.67% | -171.60% | Upgrade
|
| EBITDA | -3.22 | -3.75 | -2.33 | -3.64 | -3.74 | -2.38 | Upgrade
|
| EBITDA Margin | -126.09% | -161.60% | -144.21% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.14 | 0.14 | 0.18 | 0.24 | 0.18 | 0.4 | Upgrade
|
| EBIT | -3.36 | -3.89 | -2.51 | -3.88 | -3.92 | -2.78 | Upgrade
|
| EBIT Margin | -131.40% | -167.63% | -155.29% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.